Arş. Gör. KEVSER KÜBRA KIRBOĞA

Yayın Ağı

Makaleler 47

1. UV-driven photocatalytic activity of ZnO nanoparticles: Experimental investigation, DFT, and molecular docking analysis

Takcı D. K., Huner T., Takcı H. A. M., KIRBOĞA K. K.

Physica B: Condensed Matter , cilt.740, 2026 (SCI-Expanded, Scopus)

2. Systems pharmacology approaches to modeling immune training and tolerance

KIRBOĞA K. K., Rudrapal M.

Current Opinion in Pharmacology , cilt.89, 2026 (SCI-Expanded, Scopus)

3. Sulfonamide Derivatives as Competitive Lactoperoxidase Inhibitors Through Integrated Experimental and Multi-Level Computational Analysis

KIRBOĞA K. K., Acar Ş., Köksal Z.

Journal of Biochemical and Molecular Toxicology , cilt.40, sa.7, 2026 (SCI-Expanded, Scopus)

4. Thermodynamic Preference of Fe2+ for a C-Terminal Coordination Site in Human Frataxin Revealed by Multiscale Simulations

KIRBOĞA K. K., KÜÇÜKSİLLE E. U.

Journal of Chemical Information and Modeling , cilt.66, sa.11, ss.6676-6694, 2026 (SCI-Expanded, Scopus)

5. Integrated virtual screening, machine learning and molecular dynamics identify novel phytochemical FabI inhibitors against MRSA

Rudrapal M., KIRBOĞA K. K.

Journal of Molecular Graphics and Modelling , cilt.145, 2026 (SCI-Expanded, Scopus)

6. Potent Multi-Target Inhibition of Cholinesterases and Carbonic Anhydrases by Iridium(III)–Phenanthroline Derivatives: Integrated Structure–Activity Relationship, Molecular Docking and Anticancer Cell Culture Studies

Köksal Z., KIRBOĞA K. K., SAĞIR F., Şahin Ç.

Drug Development Research , cilt.87, sa.2, 2026 (SCI-Expanded, Scopus)

7. Marine algae-derived polyamines and phlorotannins as cholinesterase inhibitors: In vitro and in silico analysis

NECİP A., IŞIK M., TÜRKEŞ C., ÜNAL D., KIRBOĞA K. K., BEYDEMİR Ş., et al.

BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY , cilt.73, 2026 (ESCI, Scopus)

8. Energy-driven innovations in computational de novo protein engineering

Kırboğa K. K.

PROGRESS IN BIOPHYSICS AND MOLECULAR BIOLOGY , cilt.199, ss.176-196, 2026 (SCI-Expanded, Scopus)

9. Brain Organoids as Emerging Platforms for Modeling Neurodegenerative Diseases: Progress, Challenges, and Future Directions

Kaya Y., KIRBOĞA K. K.

Journal of Neurochemistry , cilt.170, sa.3, 2026 (SCI-Expanded, Scopus)

10. Axially quinoline-substituted silicon phthalocyanines: Synthesis, characterization, molecular modeling and biological evaluation against cholinesterases and carbonic anhydrases

Ünlü S., Köksal Z., Kübra Kırboğa K. K., TÜNCEL ELMALI F.

Journal of Molecular Structure , cilt.1353, 2026 (SCI-Expanded, Scopus)

11. Structure-Based Virtual Screening of Plant-Derived Flavonoids as Putative GLUT9 Binders with Antioxidant Properties

KIRBOĞA K. K., AKTAŞ E., KÜÇÜKSİLLE E. U., Rudrapal M.

Molecules , cilt.31, sa.4, 2026 (SCI-Expanded, Scopus)

12. Dynamics-informed RFdiffusion for de novo design of binders against the KRAS conformational ensemble

KIRBOĞA K. K.

Journal of Biomolecular Structure and Dynamics , 2026 (SCI-Expanded, Scopus)

13. Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation‐Resistant Frataxin

Kırboğa K. K.

PROTEINS: STRUCTURE, FUNCTION AND GENETICS , cilt.1, ss.1-20, 2026 (SCI-Expanded, Scopus)

14. Shared molecular mechanisms in aging and neurodegenerative diseases: from mechanistic insights to therapeutic strategies

Kaya Y., KIRBOĞA K. K.

Frontiers in Human Neuroscience , cilt.20, 2026 (SCI-Expanded, Scopus)

15. Decoding PI3K isoform selectivity through an ensemble-based framework integrating correlated motions, allosteric networks, and hydration thermodynamics

KIRBOĞA K. K., Keles E.

Journal of Biomolecular Structure and Dynamics , 2026 (SCI-Expanded, Scopus)

16. Neuroprotective potential of Garcinia extracts against diabetic peripheral neuropathy: GC–MS profiling, network pharmacology, molecular docking, and in vitro studies

Paul A., Kumar M., Sharma D., KIRBOĞA K. K., Rudrapal M., Chowdhury P., et al.

3 Biotech , cilt.15, sa.12, 2025 (SCI-Expanded, Scopus)

17. Identification of novel antibacterial DHFR inhibitors against MRSA through pharmacophore-based virtual screening and molecular dynamics simulation

KIRBOĞA K. K., Rudrapal M., Khan J.

Letters in Drug Design and Discovery , cilt.22, sa.11, 2025 (SCI-Expanded, Scopus)

18. Transparent machine-learning models advancing non-invasive diagnostics in bladder cancer dynamics from infrared spectral patterns

KIRBOĞA K. K., Yılmaz A. H., GURBANOV R.

Microchemical Journal , cilt.218, 2025 (SCI-Expanded, Scopus)

19. Identification of potential antigenic proteins and epitopes for the development of a monkeypox virus vaccine: an in silico approach

AKTAŞ E., SEZERMAN O. U., Özer M., KIRBOĞA K. K., Köseoğlu A. E., Özgentürk N. Ö.

Molecular Diversity , cilt.29, sa.5, ss.4273-4291, 2025 (SCI-Expanded, Scopus)

20. Computational aesthetics in dystopian visualization: an integrated approach using python programming and adobe photoshop's generative features

Bebek O., Kırboğa K. K., Coşar M.

Journal for the Interdisciplinary Art and Education , cilt.6, sa.3, ss.211-224, 2025 (Hakemli Dergi)

21. Phenolic Content, Antioxidant Capacity, and Therapeutic Potential of Mango (Mangifera indica L.) Leaves

IŞIK M., Dikici E., Altın S., ALP C., KIRBOĞA K. K., KÖKSAL E., et al.

Food Science and Nutrition , cilt.13, sa.5, 2025 (SCI-Expanded, Scopus)

22. Explainable machine learning for statistical prediction of polymer fiber properties using process parameters

Kırboğa K. K., Boz B., Mindivan F.

HACETTEPE JOURNAL OF MATHEMATICS AND STATISTICS , cilt.54, sa.3, ss.1021-1048, 2025 (SCI-Expanded, Scopus)

23. Bioinformatics-Driven Structural and Pharmacological Analysis of SLITRK1 in Tourette Syndrome: Impact of S656M Mutation Using Molecular Dynamics, Docking, and Reinforcement Learning

AKTAŞ E., İslim A., KIRBOĞA K. K., Yıldız D., Özgentürk N. Ö., Rudrapal M., et al.

Computation , cilt.13, sa.2, 2025 (ESCI, Scopus)

24. Review of the relationship between growth hormone and SARS-CoV-2 infection

Rasmi Y., KIRBOĞA K. K., Roshanravan N., Tekin B., Jalali L., Ghazizadeh F.

Future Virology , cilt.20, sa.5, ss.171-185, 2025 (SCI-Expanded, Scopus)

25. Therapeutic potential of Laurus nobilis extract by experimental and computational approaches: phenolic content and bioactivities for antioxidant, antidiabetic, and anticholinergic properties

Altın S., IŞIK M., ALP C., Dikici E., KÖKSAL E., KIRBOĞA K. K., et al.

Frontiers in Chemistry , cilt.13, 2025 (SCI-Expanded, Scopus)

26. Exploring the Genome-wide Expression Level of the Bacterial Strain Belonging to Bacillus safensis (MM19) Against Phomopsis viticola

SİLME R. S., Baysal Ö., Can A., Kürüm Y., Korkut A., KIRBOĞA K. K., et al.

Current Microbiology , cilt.81, sa.12, 2024 (SCI-Expanded, Scopus)

27. Spectrochemical and explainable artificial intelligence approaches for molecular level identification of the status of critically ill patients with COVID-19

Tokgoz G., KIRBOĞA K. K., ÖZEL F., YÜCEPUR S., ARDAHANLI İ., GURBANOV R.

Talanta , cilt.279, 2024 (SCI-Expanded, Scopus)

28. Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints

Rudrapal M., KIRBOĞA K. K., Abdalla M., Maji S.

Molecular Diversity , cilt.28, sa.4, ss.2099-2118, 2024 (SCI-Expanded, Scopus)

29. Data mining and molecular dynamics analysis to detect HIV-1 reverse transcriptase RNase H activity inhibitor

Ghafoor N. A., KIRBOĞA K. K., Baysal Ö., Süzek B. E., SİLME R. S.

Molecular Diversity , cilt.28, sa.4, ss.1869-1888, 2024 (SCI-Expanded, Scopus)

30. Explainable artificial intelligence in the design of selective carbonic anhydrase I-II inhibitors via molecular fingerprinting

KIRBOĞA K. K., IŞIK M.

Journal of Computational Chemistry , cilt.45, sa.18, ss.1530-1539, 2024 (SCI-Expanded, Scopus)

31. Feature Engineering-Assisted Drug Repurposing on Disease-Drug Transcriptome Profiles in Gastric Cancer

KIRBOĞA K. K., Rudrapal M.

Assay and Drug Development Technologies , cilt.22, sa.4, ss.181-191, 2024 (SCI-Expanded, Scopus)

32. Synthesis of cellulose nanocrystals from spinach waste for insulin delivery: comparison to chitosan nanoparticles

Esmaeili J., Pirzadeh K., Pakrooyan M., Esmaeilpour Lukolayeh M., KIRBOĞA K. K.

New Journal of Chemistry , cilt.48, sa.17, ss.7953-7963, 2024 (SCI-Expanded, Scopus)

33. Bladder cancer gene expression prediction with explainable algorithms

KIRBOĞA K. K.

Neural Computing and Applications , cilt.36, sa.4, ss.1585-1597, 2024 (SCI-Expanded, Scopus)

34. Exploring the antifungal potential of Cannabis sativa-derived stilbenoids and cannabinoids against novel targets through in silico protein interaction profiling

KIRBOĞA K. K., Karim A., KÜÇÜKSİLLE E. U., Rudrapal M., Khan J., Achar R. R., et al.

Frontiers in Chemistry , cilt.12, 2024 (SCI-Expanded, Scopus)

35. Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results

Baysal Ö., Genç D., SİLME R. S., KIRBOĞA K. K., Çoban D., Ghafoor N. A., et al.

Anti-Cancer Agents in Medicinal Chemistry , cilt.24, sa.5, ss.334-347, 2024 (SCI-Expanded, Scopus)

36. Identifying Cardiovascular Disease Risk Factors in Adults with Explainable Artificial Intelligence

KIRBOĞA K. K., KÜÇÜKSİLLE E. U.

Anatolian Journal of Cardiology , cilt.27, sa.11, ss.657-663, 2023 (SCI-Expanded, Scopus, TRDizin)

37. Ignition of Small Molecule Inhibitors in Friedreichs Ataxia with Explainable Artificial Intelligence

KIRBOĞA K. K., KÜÇÜKSİLLE E. U., KÖSE U.

Asociatia LUMEN , cilt.14, 2023 (Hakemli Dergi)

38. Explainability and white box in drug discovery

KIRBOĞA K. K., Abbasi S., KÜÇÜKSİLLE E. U.

Chemical Biology and Drug Design , cilt.102, sa.1, ss.217-233, 2023 (SCI-Expanded, Scopus)

39. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients

KIRBOĞA K. K., KÜÇÜKSİLLE E. U., NALDAN M. E., IŞIK M., Gülcü O., Aksakal E.

Computer Methods and Programs in Biomedicine , cilt.233, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Gold nanoparticle-based strategies against SARS-CoV-2: A review

Rasmi Y., KIRBOĞA K. K., Khan J., Gupta E., Mostafa F., Yallapu M. M., et al.

Reviews on Advanced Materials Science , cilt.62, sa.1, 2023 (SCI-Expanded, Scopus)

41. Detection of new candidate compounds against four antibiotic targets using explainable artificial intelligence by molecular fingerprints

KIRBOĞA K. K., Ghafoor N. A., BAYSAL Ö.

International Journal of Multidisciplinary Studies and Innovative Technologies , 2023 (Hakemli Dergi)

42. Applications of Turmeric Starch and Curcumin

KIRBOĞA K. K.

Bayburt Üniversitesi Fen Bilimleri Dergisi , 2023 (TRDizin)

43. Development of gold nanoparticle-based biosensors for COVID-19 diagnosis

Khan J., Rasmi Y., Kırboğa K. K., Ali A., Rudrapal M., Patekar R. R.

Beni-Suef University Journal of Basic and Applied Sciences , cilt.11, sa.1, 2022 (Scopus)

44. The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity

Rasmi Y., Heidari N., Kübra Kırboğa K. K., Hatamkhani S., Tekin B., Alipour S., et al.

Clinical Biochemistry , cilt.104, ss.1-12, 2022 (SCI-Expanded, Scopus)

45. Decellularized Alstroemeria flower stem modified with chitosan for tissue engineering purposes: A cellulose/chitosan scaffold

Esmaeili J., Jadbabaee S., Far F. M., Lukolayeh M. E., Kırboğa K. K., Rezaei F. S., et al.

International Journal of Biological Macromolecules , cilt.204, ss.321-332, 2022 (SCI-Expanded, Scopus)

46. Perspectives on Computer Aided Drug Discovery

KIRBOĞA K. K., KÜÇÜKSİLLE E. U.

Dicle Üniversitesi Fen Bilimleri Enstitüsü Dergisi , cilt.11, 2022 (TRDizin)

47. The Impact of Artificial Intelligence on the Medical Area: Detailed Review

KIRBOĞA K. K., KÜÇÜKSİLLE E. U., KÖSE U.

JOMUDE , cilt.6, sa.1, ss.54-73, 2021 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Harnessing Deep Reinforcement Learning for Personalized Cancer Treatment: Opportunities and Challenges

KIRBOĞA K. K.

5 th International Conference on Engineering and Applied Natural Sciences, Türkiye, 25 Ağustos 2024, (Tam Metin Bildiri)

2. Identification and Analysis of Cancer-Associated and Dysfunctional Non-Globular Proteins: A Bioinformatics Approach

KIRBOĞA K. K.

2 nd MEETING on MACHINE LEARNING AND NON-GLOBULAR PROTEINS, Thessaloniki, Yunanistan, 14 - 17 Mayıs 2024, (Özet Bildiri)

3. XAI-PT: Exploring Post-Transcriptional Biology with Explainable Artificial Intelligence

KIRBOĞA K. K.

4TH INTERNATIONAL CONFERENCE ON INNOVATIVE ACADEMIC STUDIES ICIAS 2024, Türkiye, 12 Mart 2024, (Özet Bildiri)

4. An Overview of Artificial Intelligence and Explainability in Pharmacovigilance

Kırboğa K. K., Çiftci B., Işık M.

2ND INTERNATIONAL CONFERENCE ON ENGINEERING, NATURAL AND SOCIAL SCIENCES, Konya, Türkiye, 4 - 06 Nisan 2023, ss.415-422, (Tam Metin Bildiri)

5. Designing enzymes and pathways using artificial intelligence for metabolicengineering

Kırboğa K. K., Işık M.

2nd International Conference on Engineering and Applied Natural Sciences, Konya, Türkiye, 10 Ekim 2022, (Özet Bildiri)

6. A Look at Computational Drug Discovery with Explainable Artificial Intelligence

KIRBOĞA K. K., KÜÇÜKSİLLE E. U.

1st International Conference on Innovative Academic Studies, Türkiye, 10 Eylül 2022, (Özet Bildiri)

7. Evaluation of the Drugs Tested in the Treatment of Covid-19 (Sars-Cov-2 Infection) on the Molecular Virus Replication

KIRBOĞA K. K.

Suleyman Demirel University Faculty of Medicine Health Symposium, Isparta, Türkiye, 01 Nisan 2019, (Özet Bildiri)

Kitaplar 3

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim